Denmark vs Israel: The number of people with susceptibility test result for rifampicin
Denmark
113
in 2021
Israel
103
in 2021
Denmark rank
106th
Israel rank
108th
The number of people with susceptibility test result for rifampicin over time
- Denmark
- Israel
How they compare
Denmark currently reports 113 against 103 in Israel, a difference of 10.
That makes Denmark's figure about 1.1 times Israel's.
Across all 5 years both countries report, Denmark has been ahead every year.
Denmark ranks 106th and Israel ranks 108th of 155 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 162 | 129.33 | 32.67 | Denmark |
| 2020s | 120.5 | 96 | 24.5 | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Denmark or Israel?
- Denmark, at 113 against 103 in Israel as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Denmark and Israel?
- 10, with Denmark ahead.
- How many years of comparable data are there for Denmark and Israel?
- 5 years are reported by both, from 2017 to 2021.
- How do Denmark and Israel rank globally for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 106th and Israel ranks 108th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.